Market Cap 5.90B
Revenue (ttm) 4.04M
Net Income (ttm) -161.00M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -3,985.15%
Debt to Equity Ratio 0.00
Volume 507,000
Avg Vol 1,282,022
Day's Range N/A - N/A
Shares Out 84.44M
Stochastic %K 54%
Beta 0.70
Analysts Strong Sell
Price Target $87.43

Company Profile

CG Oncology, Inc., a late-stage clinical biopharmaceutical company, develops and commercializes cretostimogene grenadenorepvec for patients with bladder cancer in the United States. The company's product candidate is cretostimogene, an investigational oncolytic immunotherapy, which is in phase 2 clinical trials of cretostimogene in patients with high-risk NMIBC after BCG failure; a phase 3 clinical trials to evaluate the safety and efficacy of cretostimogene as monotherapy in the treatment of pa...

Industry: Biotechnology
Sector: Healthcare
Phone: 949 409 3700
Address:
400 Spectrum Center Drive, Suite 2040, Irvine, United States
Buy_SoFi
Buy_SoFi Apr. 24 at 7:52 PM
$1.00+ by EoY Ferring already partnered with $TLTFF and I can only assume the new cohort of test patients are in the process of being treated for NMIBC. More partners will probably knock on the door; MIBC, GBM/Brain, Lung, pancreatic and HSV topical treatment. This has a multi-dollar buyout written all over... $IBRX $GSK $CGON $JNJ
0 · Reply
PlutoAnalyses
PlutoAnalyses Apr. 24 at 3:19 PM
$CGON this is the full analysis: If you want to know what the valuation of a clinical stage bladder cancer focused company might loon like check out my article on Substack: There are many benefits, of CGON’s drug Creto, but also some potential caveats for example the DoR. The article is free. https://open.substack.com/pub/plutoanalyses/p/cg-oncology-the-institutional-crown?r=5e6tza&utm_medium=ios
0 · Reply
PlutoAnalyses
PlutoAnalyses Apr. 24 at 2:49 PM
$CGON VALUATION OUT NOW 1. Safety & efficacy are superior to $IBRX's Anktiva in bladder cancer. 2. 700M in cash, providing runway to complete trials and negotiating leverage 3. great buyout target PLUTO VALUE: 2.13x Read the full article for free here: https://open.substack.com/pub/plutoanalyses/p/cg-oncology-the-institutional-crown?utm_campaign=post-expanded-share&utm_medium=web $IBB $XBI
2 · Reply
IronManResurrection
IronManResurrection Apr. 24 at 1:46 PM
$CGON $IBRX how does one not understand Anktiva is complimentary with almost every treatment vector? It could be relegated to a supporting role across the entire spectrum of illness and infection. It’s either making the treatment plan more efficacious or rescuing the SoC. It’s a win-win, only a juvenile untrained mind goes head-to-head with rigid exclusionary thinking.
1 · Reply
PlutoAnalyses
PlutoAnalyses Apr. 24 at 1:16 PM
Got this one guy @BenUnknown feelings hurt. He thinks $IBRX is not going to compete in NMIBC against $CGON because of the MoA. Cytokine is just part of Creto’s mechanism. The bottom line it that its better than Anktiva in bot safety and tolerability but not in PFS.
2 · Reply
OmarKingW
OmarKingW Apr. 24 at 12:52 PM
$CGON $IBRX MUTE/BLOCK
1 · Reply
PlutoAnalyses
PlutoAnalyses Apr. 24 at 12:46 PM
$CGON analysis coming at 10:30 today. Could Creto beat $IBRX’s Anktiva?
1 · Reply
Buy_SoFi
Buy_SoFi Apr. 24 at 6:20 AM
$CGON $IBRX Nah... $TLTFF Has a much better and more promising pipeline than $CGON. I STRONGLY suggest doing DD on theralase, once in a lifetime opportunity at rock bottom price. Generational wealth making opportunity.
0 · Reply
PlutoAnalyses
PlutoAnalyses Apr. 23 at 11:09 PM
Gonna post a $CGON analysis tomorrow. 111% of CGON shares are held by institutions. This makes the stock super interesting to me. It seems like many institutions are longing the stock, while others are shorting it.
0 · Reply
PlutoAnalyses
PlutoAnalyses Apr. 23 at 11:00 PM
What are people thinking about $CGON over $IBRX?
3 · Reply
Latest News on CGON
CG Oncology Announces New Board Member and Board Transition

Nov 26, 2025, 7:00 AM EST - 5 months ago

CG Oncology Announces New Board Member and Board Transition


CG Oncology Stock Signals Bullish Momentum Ahead

Sep 8, 2025, 9:08 AM EDT - 8 months ago

CG Oncology Stock Signals Bullish Momentum Ahead


CG Oncology Completes Enrollment in PIVOT-006

Sep 3, 2025, 8:00 AM EDT - 8 months ago

CG Oncology Completes Enrollment in PIVOT-006


CG Oncology Announces Pricing of Public Offering

Dec 12, 2024, 8:19 PM EST - 1 year ago

CG Oncology Announces Pricing of Public Offering


CG Oncology Announces Proposed Public Offering

Dec 11, 2024, 6:17 AM EST - 1 year ago

CG Oncology Announces Proposed Public Offering


Biotech's First IPO of 2024 Popped 96%. What It Means.

Jan 26, 2024, 11:50 AM EST - 2 years ago

Biotech's First IPO of 2024 Popped 96%. What It Means.


CG Oncology valued at $1.75 bln in strong market debut

Jan 25, 2024, 1:46 PM EST - 2 years ago

CG Oncology valued at $1.75 bln in strong market debut


Buy_SoFi
Buy_SoFi Apr. 24 at 7:52 PM
$1.00+ by EoY Ferring already partnered with $TLTFF and I can only assume the new cohort of test patients are in the process of being treated for NMIBC. More partners will probably knock on the door; MIBC, GBM/Brain, Lung, pancreatic and HSV topical treatment. This has a multi-dollar buyout written all over... $IBRX $GSK $CGON $JNJ
0 · Reply
PlutoAnalyses
PlutoAnalyses Apr. 24 at 3:19 PM
$CGON this is the full analysis: If you want to know what the valuation of a clinical stage bladder cancer focused company might loon like check out my article on Substack: There are many benefits, of CGON’s drug Creto, but also some potential caveats for example the DoR. The article is free. https://open.substack.com/pub/plutoanalyses/p/cg-oncology-the-institutional-crown?r=5e6tza&utm_medium=ios
0 · Reply
PlutoAnalyses
PlutoAnalyses Apr. 24 at 2:49 PM
$CGON VALUATION OUT NOW 1. Safety & efficacy are superior to $IBRX's Anktiva in bladder cancer. 2. 700M in cash, providing runway to complete trials and negotiating leverage 3. great buyout target PLUTO VALUE: 2.13x Read the full article for free here: https://open.substack.com/pub/plutoanalyses/p/cg-oncology-the-institutional-crown?utm_campaign=post-expanded-share&utm_medium=web $IBB $XBI
2 · Reply
IronManResurrection
IronManResurrection Apr. 24 at 1:46 PM
$CGON $IBRX how does one not understand Anktiva is complimentary with almost every treatment vector? It could be relegated to a supporting role across the entire spectrum of illness and infection. It’s either making the treatment plan more efficacious or rescuing the SoC. It’s a win-win, only a juvenile untrained mind goes head-to-head with rigid exclusionary thinking.
1 · Reply
PlutoAnalyses
PlutoAnalyses Apr. 24 at 1:16 PM
Got this one guy @BenUnknown feelings hurt. He thinks $IBRX is not going to compete in NMIBC against $CGON because of the MoA. Cytokine is just part of Creto’s mechanism. The bottom line it that its better than Anktiva in bot safety and tolerability but not in PFS.
2 · Reply
OmarKingW
OmarKingW Apr. 24 at 12:52 PM
$CGON $IBRX MUTE/BLOCK
1 · Reply
PlutoAnalyses
PlutoAnalyses Apr. 24 at 12:46 PM
$CGON analysis coming at 10:30 today. Could Creto beat $IBRX’s Anktiva?
1 · Reply
Buy_SoFi
Buy_SoFi Apr. 24 at 6:20 AM
$CGON $IBRX Nah... $TLTFF Has a much better and more promising pipeline than $CGON. I STRONGLY suggest doing DD on theralase, once in a lifetime opportunity at rock bottom price. Generational wealth making opportunity.
0 · Reply
PlutoAnalyses
PlutoAnalyses Apr. 23 at 11:09 PM
Gonna post a $CGON analysis tomorrow. 111% of CGON shares are held by institutions. This makes the stock super interesting to me. It seems like many institutions are longing the stock, while others are shorting it.
0 · Reply
PlutoAnalyses
PlutoAnalyses Apr. 23 at 11:00 PM
What are people thinking about $CGON over $IBRX?
3 · Reply
Buy_SoFi
Buy_SoFi Apr. 23 at 6:01 PM
$TLTFF <---- Multi-multi bagger in the making. Mark this post. $CGON $MRK $IBRX $GSK
0 · Reply
Buy_SoFi
Buy_SoFi Apr. 23 at 4:14 PM
$TLTFF Keeps moving up... Still cheap! Don't miss out... - HSV Topical (better than anything on market) - NMIBC - MIBC - Brain/GBM - Lung - Ruvidar + Rutherin - Ferring Partnership $MRK $CGON $IBRX $GSK
0 · Reply
Buy_SoFi
Buy_SoFi Apr. 21 at 2:36 PM
$TLTFF 100% CR and survival for X-Ray activated Rutherin for MIBC. WOW! Topical Ruvidar showing better results for HSV than anything available on the market. $MRK $IBRX $CGON $GSK
0 · Reply
Doozio
Doozio Apr. 19 at 3:40 PM
$CGON Thursday 🐑 🎁 ONTO…..
0 · Reply
BioPM1989
BioPM1989 Apr. 18 at 10:21 PM
$TYRA Don't think the erda PK translates here... Prefer deep value for NMIBC like $CGON
0 · Reply
Grinding10
Grinding10 Apr. 17 at 9:34 PM
$CGON 🤷‍♂️anyone want this 👊take my 30 years of trading bios or don’t I don’t really give a fuck anymore 😃KNEL 🫵✌️still here but goals getting achieved and trimming accordingly 🤷‍♂️still monster in IRA; done posting 👍
1 · Reply
JuggernautRaider
JuggernautRaider Apr. 17 at 7:58 PM
$CGON hell of a run 🏃‍♂️
0 · Reply
anachartanalyst
anachartanalyst Apr. 17 at 5:02 PM
$CGON https://anachart.com/wp-content/uploads/ana_temp/1776445301_soc-img.jpg
0 · Reply
Quantumup
Quantumup Apr. 17 at 12:24 PM
Cantor reiterated $TYRA at an Overweight rating $URGN $CGON JNJ IBRX Here's what Cantor said in its note: https://x.com/Quantumup1/status/2045115106401431856?s=20
0 · Reply
Grinding10
Grinding10 Apr. 16 at 2:55 PM
$CGON jump on this anyone who knows; Easy manipulated tanking before approval or results for insiders on nothing; 🤷‍♂️👊Take it or leave it don’t care I know my bios 😃
0 · Reply
IPOtweet
IPOtweet Apr. 16 at 12:40 PM
CG Oncology has delivered strong gains since its IPO—driven by positive trial data, a faster development timeline, and growing institutional backing. Momentum often follows data in the biotech sector. When the story strengthens, capital follows. Track IPO performance and emerging winners with IPO Pro: ipopro.renaissancecapital.com $CGON $IPO $IPOS #IPO #Biotech
0 · Reply
Grinding10
Grinding10 Apr. 15 at 5:57 AM
$CGON 1st half ⏱️ expedited results; time to shine; nitro zone; be there or not 🤷‍♂️; there’s zero board here so congrats to myself; This will be $95 or bought out by July 😎🫵; 3 years in decent average $34; do ursekf a favor I’m a bio man this is NITRO ZONE; check ISEE or SWAV last couple years for what I mean; blew one hot one; don’t follow me; make 💵💵on my patience; reminds me of 1 drug Regeneron and look at that chart👍Times ticking; don’t want follower’s etc just get in😎🤙
0 · Reply